Table 1.
Demographic and clinical characteristics of the HCM cohort (n=112).
| Age (years) | 49±15 |
|---|---|
| Male | 73 (65) |
| NYHA Class I | 45 (40) |
| NYHA Class II | 37 (33) |
| NYHA Class III | 14 (12.5) |
| Symptoms | |
| Angina | 36 (32) |
| Dyspnea | 47 (42) |
| Presyncope, syncope | 15 (13) |
| Palpitations | 14 (12.5) |
| Dizziness | 19 (17) |
| Arrhythmia (NSVT, VT) | 30 (27) |
| Medications | |
| Beta-blockers | 73 (65) |
| CCB | 19 (17) |
| ACEi /ARB | 17 (15) |
| ICD | 37 (33) |
Values in parentheses indicate percentages. NYHA: New York Heart Association; CCB: calcium-channel blockers, ACEi: angiotensin-converting enzyme inhibitors; ARB: angiotensin receptor blocker. Arrhythmia: non-sustained ventricular tachycardia (NSVT) and sustained ventricular tachycardia (VT).